Successful arterial administration therapy of SMANCS for liver metastasis of malignant insulinoma.
Igarashi
H
H
Third Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Ito
T
T
Ogoshi
K
K
Kuroiwa
T
T
Koyanagi
S
S
Arita
Y
Y
Sumii
T
T
Nawata
H
H
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D007340:Insulinoma / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D008299:Maleic Anhydrides / Q000008:administration & dosage / Q000627:therapeutic use*; D018761:Multiple Endocrine Neoplasia Type 1 / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D011137:Polystyrenes / Q000008:administration & dosage / Q000627:therapeutic use*; D013157:Splenic Artery; D009353:Zinostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008299:Maleic Anhydrides; D011137:Polystyrenes; C035755:poly(maleic acid-styrene)neocarzinostatin; D009353:Zinostatin